Screening and diagnosis of triple negative breast cancer based on rapid metabolic fingerprinting by conductive polymer spray ionization mass spectrometry and machine learning
Authors:
Open Access
- 15 December 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 1075810
Abstract
We present the use of conductive spray polymer ionization mass spectrometry (CPSI-MS) combined with machine learning (ML) to rapidly gain the metabolic fingerprint from 1 μl liquid extraction from the biopsied tissue of triple-negative breast cancer (TNBC) in China. The 76 discriminative metabolite markers are verified at the primary carcinoma site and can also be successfully tracked in the serum. The Lasso classifier featured with 15- and 22-metabolites detected by CPSI-MS achieve a sensitivity of 88.8% for rapid serum screening and a specificity of 91.1% for tissue diagnosis, respectively. Finally, the expression levels of their corresponding upstream enzymes and transporters have been initially confirmed. In general, CPSI-MS/ML serves as a cost-effective tool for the rapid screening, diagnosis, and precise characterization for the TNBC metabolism reprogramming in the clinical practice.Keywords
This publication has 41 references indexed in Scilit:
- Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosisGenome Medicine, 2016
- Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapyCancer Science, 2016
- Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics and Other Clinical MeasurementsClinical Chemistry, 2016
- Metabolomics Biomarkers for Breast CancerPathobiology, 2015
- Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors2014
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor GenesScience, 2010
- Histone arginine methylationFEBS Letters, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- MetabonomicsNature, 2008
- Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatmentThe Lancet Oncology, 2005